The University of Notre Dame Australia’s Institute for Health Research (IHR) and MGC Pharma have announced publication of the study protocol for a clinical trial evaluating medical cannabis use with patients with dementia.

The trial was registered in the Australian and New Zealand Clinical Trial Register (ANZCTR) earlier this week. The research project, which we again recently mentioned here on Hemp Gazette,  will delve into the effects of medicinal cannabis oil among those living in a residential aged care facility medically diagnosed with dementia.

Aside from the euphoria, probably the most common effect of cannabis is — to avoid using a medical term — munchies. The substance has shown good results in treating patients suffering from wasting diseases, such as AIDS, by reducing nausea and increasing appetite. It has promising potential treating Anorexia Nervosa, one of the most common and dangerous eating disorders, but it isn’t a cure and the science isn’t complete

A new study has shown that the cannabis cannabinoid CBD helps to fight resistant bacteria by improving the efficacy of antibiotics.

Scientists at the University of Southern Denmark have published a new study in the journal Scientific Reports that shows how CBD can act as a ‘helper compound’ to improve the efficacy of antibiotics.

From easing inflammation to helping with better sleep to ignite more effective workouts, CBD is being used by pro-athletes and those in gyms all over the globe.

Athletes all over the country are looking for upgrades to hack their regimen to faster success. One method gaining traction is infusing CBD or cannabis before workouts to better help the body stretch, as well as after workouts to ease inflammation and pain. 

One sector of the business world that has seen a much-needed spike during the coronavirus pandemic is cannabis sales, which are hitting new highs as people stockpile pot while electing or being ordered to stay home.

Sales for the week of March 16-22 show cannabis markets in California, Colorado, Oregon and Alaska — all legal recreational markets — were up 50%, while medicinal sales rose 41% for the week year over year.

Nonessential businesses across the U.S. and Canada have been ordered temporarily shut down or had their operations restricted to help combat the spread of the novel coronavirus, which has now killed more than 800 people in the two countries (though, less than 30 are in Canada).

The cannabis industry has gone through a rough period lately. After building extremely high expectations in 2018 with the legalization of recreational marijuana in Canada, marijuana stocks suffered significant losses in 2019. Just when it looked as though 2020 might be a better year for the cannabis industry, disruptions related to the coronavirus outbreak added new challenges.

Unless you’ve been living at the bottom of a rock, you’ve likely heard about CBD, the cannabis extract that medical experts now recommend for a broad spectrum of conditions. CBD, or cannabidiol, is one of the many compounds that are derived from the cannabis plant. 

There are several health conditions that cannabidiol is touted to treat, including;

1. Pain and inflammation,
2. Anxiety-related disorders, such as chronic anxiety and post-traumatic stress disorder,
3. Multiple sclerosis,
4. Alzheimer’s disease, etc.

Among the many health benefits of CBD is its potential to treat endometriosis.

In order for cannabis and its hundreds of constituents to contribute to mainstream healthcare in a quantifiable way, it needs research-backed legitimacy. And that’s why, right now, we’re in the middle of a research boom. Scientists, doctors, and researchers are looking into why CBD (in particular, due to its non-psychoactive properties) makes an amazing, accessible treatment option. And especially in the area of pain.

Marijuana stocks have without a doubt, taken a beating these last few months. Around six months ago, we saw some issues such as supply bottlenecks and the rising black market, both take their respective tolls on pot stock prices. Since that time, the largest catalyst to cannabis stocks has been the coronavirus. We can’t say that cannabis is the only industry being hit right now as the coronavirus has been wreaking havoc across all world markets. But, with any downtrodden time, there usually is an uptrend waiting to take hold.

Some aspects of CBD make it worth investigating when it comes to heart disease prevention, like the compound’s anti-inflammatory and antioxidant features.

CBD studies have demonstrated positive evidence when it comes to treating and preventing a range of illnesses, including degenerative diseases, cancer and metabolic disorders. But what about preventing heart disease and promoting heart health?